AV
ABS Ventures
Venture CapitalActiveFormed in 1982, ABS Ventures is a Boston-based venture capital firm backed by leading global institutional investors.
81
Investments
5
Exits
$500M
AUM
6.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for ABS Ventures.
Investment Thesis & Strategy
ABS Ventures invests in various stages of advertising/marketing and SaaS companies, leveraging its network of global institutional investors.
Investment Activity
Deals per year over the last 15 years
1
20000
20010
20022
20031
20041
20050
20061
20074
20080
20090
20100
20110
20120
20131
2014Portfolio Companies
Selected investments from their portfolio of 81 companies
E
Enanta Pharmaceuticals
Biotech · Series A, 0
S
Syntimmune
Biotech · Series A, 2014
C
Catabasis Pharmaceuticals
Biotech · Series A, 2008
T
Tetraphase Pharmaceuticals
Biotech · Series A, 2008
A
Aegerion Pharmaceuticals
Biotech · Series A, 2008
E
Esperion Therapeutics
Biotech · Series A, 2008
E
Epizyme
Biotech · Series A, 2007
P
Portola Pharmaceuticals
Biotech · Series A, 2005
R
Radius Health
Biotech · Series A, 2004
A
Acceleron Pharma
Biotech · Series A, 2003
A
Acceleron Pharma
Biotech · Series A, 2003
A
Alnylam Pharmaceuticals
Biotech · Series A, 2000
Notable Exits
CompanyTypeYearValue / Acquirer
Bill.comIPO2019$1.5B
Coupa SoftwareIPO2016$800M
ServiceMaxAcquisition2016$915M
MarketoAcquisition2016$1.79B
Cast Iron SystemsAcquisition2010—
Frequently Asked Questions
ABS Ventures focuses on Series A, Series B, Series C+ stage investments.